Three-Component Access to Functionalized Spiropyrrolidine Heterocyclic Scaffolds and Their Cholinesterase Inhibitory Activity
Sarra Boudriga,
Saoussen Haddad,
Vikneswaran Murugaiyah,
Moheddine Askri,
Michael Knorr,
Carsten Strohmann,
Christopher Golz
Affiliations
Sarra Boudriga
Department of Chemistry, Laboratory of Heterocyclic Chemistry Natural Product and Reactivity/CHPNR, Faculty of Science of Monastir, Monastir 5000, Tunisia
Saoussen Haddad
Department of Chemistry, Laboratory of Heterocyclic Chemistry Natural Product and Reactivity/CHPNR, Faculty of Science of Monastir, Monastir 5000, Tunisia
Vikneswaran Murugaiyah
Discipline of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, USM 11800, Penang, Malaysia
Moheddine Askri
Department of Chemistry, Laboratory of Heterocyclic Chemistry Natural Product and Reactivity/CHPNR, Faculty of Science of Monastir, Monastir 5000, Tunisia
Michael Knorr
Institut UTINAM-UMR CNRS 6213, Université Bourgogne Franche-Comté, 16 Route de Gray, 25030 Besançon, France
Carsten Strohmann
Technische Universität Dortmund, Anorganische Chemie Otto-Hahn-Straße 6, 44221 Dortmund, Germany
Christopher Golz
Technische Universität Dortmund, Anorganische Chemie Otto-Hahn-Straße 6, 44221 Dortmund, Germany
A novel one-pot [3+2]-cycloaddition reaction of (E)-3-arylidene-1-phenyl-succinimides, cyclic 1,2-diketones (isatin, 5-chloro-isatin and acenaphtenequinone), and diverse α-aminoacids such as 2-phenylglycine or sarcosine is reported. The reaction provides succinimide-substituted dispiropyrrolidine derivatives with high regio- and diastereoselectivities under mild reaction conditions. The stereochemistry of these N-heterocycles has been confirmed by four X-ray diffraction studies. Several synthetized compounds show higher inhibition on acetylcholinesterase (AChE) than butyrylcholinesterase (BChE). Of the 17 synthesized compounds tested, five exhibit good AChE inhibition with IC50 of 11.42 to 22.21 µM. A molecular docking study has also been undertaken for compound 4n possessing the most potent AChE inhibitory activity, disclosing its binding to the peripheral anionic site of AChE enzymes.